Vaccine panel that limited covid shot scrutinized
Digest more
CDC panel votes to change MMRV, COVID-19 vaccine guidance
Digest more
In a Q&A with STAT, Nobel winner Drew Weissman addressed concerns raised about Covid shots at a recent meeting of federal vaccine advisers.
The CDC's Advisory Committee on Immunization Practices, with members appointed by RFK Jr., is meeting to discuss and vote on COVID-19 vaccine recommendations.
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups
Florida Surgeon General Joseph Ladapo says he does not want mRNA COVID-19 vaccines to be available in Florida. In a podcast interview published Sunday, Ladapo was asked about thestate’s announcementthis month that officials intended to end all vaccine mandates.
Last month, the Department of Health and Human Services (HHS) cancelled $500 million in funding for mRNA vaccine research and development. This decision will have devastating consequences.
Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories
Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and territories. This milestone advances Canada's domestic vaccine production capacity and
COVID-19 vaccination guidance. The new guidance continues to recommend that all individuals, including children from six months to 18 years old, and at-risk people get the vaccine. This also includes people who are pregnant and immunocompromised.
The Pitt medical community expressed unease about the future of public health after the Department of Health and Human Services announced it would begin the coordinated wind-down of mRNA vaccine development activities on Aug.
GlobalData on MSN
As US funding falters, mRNA cancer vaccine pioneers face new hurdles
Cuts to mRNA vaccine funding in the US have stalled infectious disease programmes, with experts warning the consequences are likely to extend to other promising therapeutic areas. It was only a matter of time before mRNA technology moved into the regulatory crosshairs of Robert F Kennedy Junior (RFK Jr).